EPM2A Gene Myoclonic Epilepsy of Lafora NGS Genetic DNA Test
Introduction
The EPM2A Gene Myoclonic Epilepsy of Lafora NGS Genetic DNA Test is a cutting-edge diagnostic tool designed to identify genetic mutations associated with Lafora disease, a rare and progressive neurological disorder characterized by myoclonic seizures and cognitive decline. Understanding the genetic basis of this condition is crucial for affected individuals and their families, as it can guide treatment decisions and inform family planning.
What the Test Measures
This test specifically analyzes the EPM2A gene, which is known to play a critical role in the development of Lafora disease. By utilizing Next Generation Sequencing (NGS) technology, the test provides an in-depth analysis of the genetic material, allowing for the detection of mutations that may contribute to the onset of this debilitating condition.
Who Should Consider This Test?
Individuals who experience symptoms such as myoclonic seizures, progressive cognitive decline, or have a family history of Lafora disease should consider the EPM2A Gene Myoclonic Epilepsy of Lafora NGS Genetic DNA Test. Additionally, those with risk factors such as a known family history of genetic epilepsy disorders may benefit from this test to better understand their genetic predisposition.
Benefits of Taking the Test
- Identifies genetic mutations that may cause Lafora disease.
- Informs patients and families about potential risks and management strategies.
- Facilitates early intervention and treatment planning.
- Provides crucial information for family planning and genetic counseling.
Understanding Your Results
Once the test results are available, they will be discussed in detail with a qualified healthcare professional. Understanding the implications of your genetic profile is vital, as it can influence treatment options and lifestyle choices. Genetic counseling is recommended to help interpret results and discuss potential next steps.
Test Name and Price
| Test Name | Discount Price | Regular Price |
|---|---|---|
| EPM2A Gene Myoclonic Epilepsy of Lafora NGS Genetic DNA Test | 400,000 NGN | 560,000 NGN |
Book the Test
For more information or to book the EPM2A Gene Myoclonic Epilepsy of Lafora NGS Genetic DNA Test, please contact us at +2348077798758. Our team is ready to assist you with any questions and guide you through the booking process.
Additional Information
Turnaround Time: 3 to 4 Weeks
Sample Type: Blood or Extracted DNA or One drop Blood on FTA Card
Pre-Test Instructions: Clinical history of the patient who is going for the test and a genetic counseling session to draw a pedigree chart of family members affected with EPM2A Gene Myoclonic Epilepsy of Lafora.
Take the first step towards understanding your genetic health today!
